A double-blind non-inferiority clinical study of montelukast, a cysteinyl leukotriene receptor 1 antagonist, compared with pranlukast in patients with seasonal allergic rhinitis

Allergology International

Volumn 57, Issue 4, 2008, Pages 383-390

  Okubo, Kimihiro ^a   Baba, Kohtaro ^b  

^a NIPPON MEDICAL SCHOOL HOSPITAL   (Japan)

^b DOKKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

Comparative double blind study; Cysteinyl leukotriene receptor; Montelukast; Pranlukast seasonal allergic rhinitis

Indexed keywords

MONTELUKAST; PLACEBO; PRANLUKAST;

ADULT; ARTICLE; BEDTIME DOSAGE; CIRCADIAN RHYTHM; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG POTENCY; DRUG SAFETY; DRUG WITHDRAWAL; EVENING DOSAGE; FEMALE; HAY FEVER; HUMAN; MAJOR CLINICAL STUDY; MALE; MORNING DOSAGE; MULTICENTER STUDY; NOSE CONGESTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RHINOPHARYNGITIS; SIDE EFFECT; SNEEZING; SOMNOLENCE; SYMPTOM; THIRST; TREATMENT DURATION;

EID: 59549105114     PISSN: 13238930     EISSN: 14401592     Source Type: Journal    
DOI: 10.2332/allergolint.O-08-533     Document Type: Article

References (15)

1. 4 receptor antagonista. Can J Physiol Pharmacol 1995; 73:191-201.
2. Konno A, Yamagoshi T, Usui S. Clinical assessment of ONO-1078 (pranlukast hydrate) against perennial allergic rhinitis - Clinical pharmacological study using airway resistance in the nasal cavity as an indicator - (A double blind comparative study using placebo as a control drug). J Clin Ther Med 1997;13:1921-39.
3. [Practical Guideline for the Management of Allergic Rhinitis in Japan - Perennial Rhinitis and Pollinosis], 5th edn. Tokyo: Life Science Publishing, 2005 (in Japanese).
4. [Practical Guideline for the Management of Allergic Rhinitis in Japan - Perennial Rhinitis and Pollinosis], 4th edn. Tokyo: Life Science Publishing, 2002 (in Japanese).
5. Chervinsky P, Philip G, Malice MP et al. Montelukast for treating fall allergic rhinitis: effect of pollen exposure in 3 studies. Ann Allergy Asthma Immunol 2004;92:367-73.
6. Okuda M. [Nasal Allergy]. Tokyo: Iyaku Journal, 1999; 397 (in Japanese).
7. Okubo K, Baba K. Therapeutic effect of montelukast, a cysteinyl leukotriene receptor 1 anatagonist, on Japanese patients with seasonal allergic rhinitis. Allergol Int 2008; 57:247-55.
8. Okuda M, Kataura A. Togawa K et al. [Clinical assessment of pranlukast - A multicenter, collaborative, double blind study using epinastine hydrochloride as a control drug]. Jibi to Rinsho [Otologia Fukuoka] 1998;44:47-72 (in Japanese).
9. Nayak AS, Philip G, Lu S, Malice MP, Reiss TF. Efficacy and tolerability of montelukast alone or in combination with loratadine in seasonal allergic rhinitis: a multicenter, randomized, double-blind, placebo-controlled trial performed in the fall. Ann Allergy Asthma Immunol 2002;88: 592-600.
10. [Pollen Information Report]. NPO Pollen Information Association (Japan), 2004 (in Japanese).
11. Philip G, Malmstrom K, Hampel FC et al. Montelukast for treating seasonal allergic rhinitis: a randomized, doubleblind, placebo-controlled trial performed in the spring. Clin Exp Allergy 2002;32:1020-8.
12. van Adelsberg J, Philip G, LaForce CF et al. Randomized controlled trial evaluating the clinical benefit of montelukast for treating spring seasonal allergic rhinitis. Ann Allergy Asthma Immunol 2003; 90:214-22.
13. van Adelsberg J, Philip G, Pedinoff AJ et al. Montelukast improves symptoms of seasonal allergic rhinitis over a 4-week treatment period. Allergy 2003; 12: 1268-76. Erratual in: Allergy. 2004; 59: 357.
14. Philip G, Nayak AS, Berger WE et al. The effect of montelukast on rhinitis symptoms in patients with asthma and seasonal allergic rhinitis. Curr Med Res Opin 2004;20: 1549-58.
15. Weinstein SF, Philip G, Hampel FC Jr et al. Onset of efficacy of montelukast in seasonal allergic rhinitis. Allergy Asthma Proc 2005;26:41-6.